Dobutamine MeSH Descriptor Data 2024

MeSH Heading: Dobutamine
Tree Number(s): D02.092.311.220; D02.092.471.683.410; D02.455.426.559.389.657.166.175.220
Unique ID: D004280
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D004280
Scope Note: A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY.
Entry Term(s): Dobucor; Dobuject; Dobutamin Fresenius; Dobutamin Hexal; Dobutamin Solvay; Dobutamin-ratiopharm; Dobutamina Inibsa; Dobutamina Rovi; Dobutamine (+)-Isomer; Dobutamine Hydrobromide; Dobutamine Hydrochloride; Dobutamine Lactobionate; Dobutamine Phosphate (1:1) Salt, (-)-Isomer; Dobutamine Tartrate; Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer; Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer; Dobutamine, (-)-Isomer; Dobutamine, Phosphate (1:1) Salt (+)-Isomer; Dobutrex; Lilly 81929; Oxiken; Posiject
Pharm Action: Cardiotonic Agents
Sympathomimetics
Adrenergic beta-1 Receptor Agonists
Registry Number: 3S12J47372
Related Numbers: 0WR771DJXV; 101626-66-8; 104564-71-8; 104564-74-1; 120885-53-2; 120885-54-3; 34368-04-2; 49745-95-1; 5D1IB9AI6J; 61661-05-0; 61661-06-1; 74753-15-4; CP0YC140T9
CAS Type 1 Name: 1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, (+-)-
Previous Indexing: Catecholamines (1974-1975); Phenethylamines (1974-1975); Phenols (1974-1975)
Public MeSH Note: 86; was see under CATECHOLAMINES 1976-85
History Note: 86(76); was see under CATECHOLAMINES 1976-85
Date Established: 1986/01/01
Date of Entry: 1975/07/18
Revision Date: 2018/06/30

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Organic Chemicals [D02]
- Amines [D02.092]
  - Catecholamines [D02.092.311]

Organic Chemicals [D02]
- Amines [D02.092]
  - Ethylamines [D02.092.471]
    - Phenethylamines [D02.092.471.683]

Organic Chemicals [D02]
- Hydrocarbons [D02.455]
  - Hydrocarbons, Cyclic [D02.455.426]
    - Hydrocarbons, Aromatic [D02.455.426.559]
      - Benzene Derivatives [D02.455.426.559.389]
        
        Phenols [D02.455.426.559.389.657]
        
        Catechols [D02.455.426.559.389.657.166]
        
        Catecholamines [D02.455.426.559.389.657.166.175]
        
        Dihydroxyphenylalanine [D02.455.426.559.389.657.166.175.200]
        
        Dobutamine [D02.455.426.559.389.657.166.175.220]
        
        Dopamine [D02.455.426.559.389.657.166.175.342]
        
        Epinephrine [D02.455.426.559.389.657.166.175.461]
        
        Isoproterenol [D02.455.426.559.389.657.166.175.649]
        
        Metaproterenol [D02.455.426.559.389.657.166.175.660]
        
        Norepinephrine [D02.455.426.559.389.657.166.175.830]

Dobutamine Preferred

Dobucor Narrower

Dobuject Narrower

Dobutamin Fresenius Narrower

Dobutamin Hexal Narrower

Dobutamin Solvay Narrower

Dobutamin-ratiopharm Narrower

Dobutamina Inibsa Narrower

Dobutamina Rovi Narrower

Posiject Narrower

Dobutamine Hydrobromide Narrower

Dobutamine Hydrochloride Narrower

Dobutamine Lactobionate Narrower

Dobutamine Tartrate Narrower

Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer Narrower

Dobutamine, (-)-Isomer Narrower

Dobutamine, Phosphate (1:1) Salt (+)-Isomer Narrower

Dobutrex Narrower

Lilly 81929 Narrower

Oxiken Narrower

Dobutamine Phosphate (1:1) Salt, (-)-Isomer Narrower

Dobutamine (+)-Isomer Narrower

page delivered in 0.168s